Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations - Yao, SK; Rosolowsky, M; Anderson, V; Golino, P; McNatt, J; De Clerck, F; Buja, LM; Willerson, JT (J Am Coll Cardiol, 1990)